These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11236223)

  • 1. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature.
    Stone ML; Styles AR; Cockerell CJ; Pandya AG
    Cutis; 2001 Feb; 67(2):133-8. PubMed ID: 11236223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients.
    Akaraphanth R; Douglass MC; Lim HW
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):33-9. PubMed ID: 10607317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypopigmented mycosis fungoides].
    Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L
    Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small malignant melanoma in patients with mycosis fungoides.
    Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypopigmented mycosis fungoides.
    Whitmore SE; Simmons-O'Brien E; Rotter FS
    Arch Dermatol; 1994 Apr; 130(4):476-80. PubMed ID: 8166485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides presenting as areas of hypopigmentation: a report of three cases.
    Zackheim HS; Epstein EH; Grekin DA; McNutt NS
    J Am Acad Dermatol; 1982 Mar; 6(3):340-5. PubMed ID: 7068962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypopigmented mycosis fungoides in a white female.
    Amichai B; Grunwald MH; Avinoach I; Halevy S
    J Dermatol; 1996 Jun; 23(6):425-6. PubMed ID: 8708157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypopigmented mycosis fungoides.
    Handfield-Jones SE; Smith NP; Breathnach SM
    Clin Exp Dermatol; 1992 Sep; 17(5):374-5. PubMed ID: 1458652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides in young patients: clinical characteristics and outcome.
    Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases.
    Lambroza E; Cohen SR; Phelps R; Lebwohl M; Braverman IM; DiCostanzo D
    J Am Acad Dermatol; 1995 Jun; 32(6):987-93. PubMed ID: 7751470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypopigmented mycosis fungoides in childhood and adolescence.
    Neuhaus IM; Ramos-Caro FA; Hassanein AM
    Pediatr Dermatol; 2000; 17(5):403-6. PubMed ID: 11085673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypopigmented mycosis fungoides. Speculations about the mechanism of hypopigmentation.
    Goldberg DJ; Schinella RS; Kechijian P
    Am J Dermatopathol; 1986 Aug; 8(4):326-30. PubMed ID: 3766921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
    Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
    Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
    Talpur R; Venkatarajan S; Duvic M
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
    Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
    JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
    Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
    Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular mycosis fungoides: a case report and review of the literature.
    DeBloom J; Severson J; Gaspari A; Scott G
    J Cutan Pathol; 2001 Jul; 28(6):318-24. PubMed ID: 11401680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
    Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
    Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study.
    Rodney IJ; Kindred C; Angra K; Qutub ON; Villanueva AR; Halder RM
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):808-814. PubMed ID: 27515575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.